Prism will be used by Healthcare Providers to enhance standard of care clinical outcomes. Prism uses an Amygdala-fMRI-guided model for processing EEG signals. Prism uses several electrodes EEG-signal to produce a real time Amygdala-derived-EFP biomarker signal to train patients in downregulating the Amygdala-derived-EFP biomarker during neurofeedback.

StarStarter Rx is currently available for release with healthcare providers, payers and virtual care providers. Our mobile casual game delivers treatment using a unique cognitive training method called Attention Bias Modification Training, and is designed to be used for 12 mnutes a day, 4 days a week for an 30 day initial course of treatment. Evidence during our most recent clinical pilot showed that >90% of patients saw symptom reduction, 68% had clinically meaningful reductions in anxiety severity levels. 

The game is fun and brief, using your ship to bounce off the walls to gather energy and bring light back to the galaxy. Integrated assessments provide support for escalation and triage. StarStarter Rx is currently being investigated as a cognitive behavioral therapy and will be submitted for FDA’s review as a treatment for Social Anxiety Disorder.

Arcade Therapeutics improve mental health outcomes through low-stigma, accessible mobile games, based on breakthrough neuroscientific research.

Our first-to-market solution, Prism for PTSD, is a promising software as a medical device for the treatment of PTSD as an adjunct to standard of care. About 250 million people worldwide live with PTSD, yet treatments are lacking and often lead to side effects that may last a lifetime. Prism for PTSD: An adjunct to standard of care therapy, was validated in a multi-center clinical trial in 5 medical centers in the USA and in Israel. While using Prism, patients learn to downregulate the amygdala-derived-EFP signal and how to control their PTSD symptoms under the supervision of a healthcare provider.